Burden of illness of HER2+in metastatic breast cancer (MBC) patients: A systematic literature review (SLR)

被引：0
|
作者：
Vondeling, G. [1 ]
Harding, T. [2 ]
Seddik, A. [3 ]
Bakker, K. [4 ]
Velikanova, R. [4 ]
机构：
[1] Univ Groningen, Groningen, Netherlands
[2] AstraZeneca, Hlth Econ & Payer Evidence, Cambridge, England
[3] Dauchi Sankyo, Global Hlth Econ & Real World Evidence, Munich, Germany
[4] Asc Acad BV, Hlth Econ & Market Access, Groningen, Netherlands
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.570
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
287P
引用
收藏
页码：S490 / S490
页数：1
相关论文
共 50 条
  • [1] A SYSTEMATIC LITERATURE REVIEW (SLR) OF ECONOMIC BURDEN OF PATIENTS WITH HORMONE RECEPTORPOSITIVE/HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HR+/HER2-) METASTATIC BREAST CANCER (MBC) WITH AT LEAST ONE PRIOR THERAPY
    Shah, A.
    Wang, T.
    Proudman, D.
    Gharaibeh, M.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S131 - S131
  • [2] Burden of illness estimates of metastatic breast cancer (MBC) in the United States
    Sorenson, S.
    Benedict, A.
    Yardley, D. A.
    Martin, M.
    Knopf, K. B.
    Pan, F.
    Goh, J.
    Giorgetti, C.
    Chen, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] THE BURDEN OF ILLNESS OF TREATMENT-INDUCED VASOMOTOR SYMPTOMS IN PATIENTS WITH BREAST CANCER: A SYSTEMATIC LITERATURE REVIEW
    Morga, A.
    Shiozawa, A.
    Todorova, L.
    Ajmera, M.
    Wissinger, E.
    Arregui, M.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S16 - S16
  • [4] TARGETED LITERATURE REVIEW OF ADVANCED/METASTATIC TRIPLE-NEGATIVE BREAST CANCER BURDEN OF ILLNESS
    Naidoo, S.
    Friedman, M. L.
    Paly, V. F.
    Hansen, R.
    Sidhu, M. K.
    Smith, I
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A94 - A95
  • [5] Predictors of survival in patients with HER2+metastatic breast cancer (MBC) treated with trastuzumab
    Olson, E. M.
    Najita, J. S.
    Sohl, J.
    Arnaout, A.
    Winer, E. P.
    Lin, N. U.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Brain metastases in HER2-overexpressing metastatic breast cancer (MBC) patients (PTS)
    Gori, S.
    Rimondini, S.
    De Angelis, V.
    Sidoni, A.
    Mosconi, A. M.
    Aristei, C.
    Perrucci, E.
    Basurto, C.
    Franceschi, E.
    Scopece, L.
    Degli Esposti, R.
    Colozza, M.
    Crino, L.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 10 - 11
  • [7] The economic burden of metastatic breast cancer: A systematic review of literature from developed countries
    Foster, Talia S.
    Miller, Jeffrey D.
    Boye, Mark E.
    Blieden, Marissa B.
    Gidwani, Risha
    Russell, Mason W.
    [J]. CANCER TREATMENT REVIEWS, 2011, 37 (06) : 405 - 415
  • [8] BURDEN OF ILLNESS AND TREATMENT PATTERNS OF ADULT PATIENTS WITH ADVANCED OR METASTATIC GASTRIC/GASTROESOPHAGEAL JUNCTION CANCER: A SYSTEMATIC LITERATURE REVIEW
    Chen, Z.
    Ajani, J.
    Yusuf, A.
    Eichinger, C.
    Majer, I
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S43 - S43
  • [9] Outcome of HER2-Positive (HER2+) Metastatic Breast Cancer Patients (MBC) Treated with Trastuzumab (T): An Institutional Based Review
    Guilhaume, M-N
    Dieras, V
    Fall, M.
    Pierga, J-Y
    Beuzeboc, P.
    Cottu, P. H.
    Simondi, C.
    Courbard, M.
    Mignot, L.
    Livartowski, A.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 801S - 801S
  • [10] PARP inhibitors (PARPi) for the treatment of BRCA-mutated HER2negative (HER2-) metastatic breast cancer (MBC) patients: A systematic review and meta-analysis.
    Poggio, Francesca
    Bruzzone, Marco
    Ceppi, Marcello
    Conte, Benedetta
    Martel, Samuel
    Maurer, Christian
    Tagliamento, Marco
    Viglietti, Giulia
    Del Mastro, Lucia
    De Azambuja, Evandro
    Lambertini, Matteo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345